viking therapeutics stock forecast 2022

Saturday, April 9, 2022 Edit

On average they expect Viking Therapeutics stock price to reach 1550 in the next year. VKTX a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic.

Zacks Brokerages Anticipate Viking Therapeutics Inc Nasdaq Vktx Will Post Earnings Of 0 20 Per Share Marketbeat

The Viking Therapeutics stock price fell by -033 on the last day Wednesday 6th Apr 2022 from 306 to 305.

. Their forecasts range from 1000 to 2100. This suggests a possible upside of. VKTX is owned by 4614 institutional shareholders 1213 Viking Therapeutics insiders and 4174 retail investors.

VKTX stock chart with full price history volume trends and moving averages. 3 2022 PRNewswire -- Viking Therapeutics Inc. As of 2022 April 04 Monday current price of VKTX stock is 3140 and our data indicates that the asset price has been in a downtrend for the past 1 year or since its inception.

SAN DIEGO April 6 2022 PRNewswire -- Viking Therapeutics Inc. Target values for the price of one AN2 Therapeutics share for Aug 2022. And has now fallen 3 days in a rowDuring the day the stock fluctuated 369 from a day low at 298 to a day high of 309The price has fallen in 6 of the last 10 days and is down by -439 for this period.

Volume has increased on the last day by. VKTX stock quote history news and other vital information to help you with your stock trading and investing. Created with Highstock 135.

The 9 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 2000 with a high estimate of 3000 and a. 2 weeks VIKING THERAPEUTICS INC share price prediction for. Stock Predictons by days.

1 day and price target of 316 USD. VKTX Stock Must Maintain Its Footing Above This Level of Price Support In the late stages of a bull market technical price patterns tend to fail trapping investors into trades that they. Viking Therapeutics Inc.

VKTX a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders today announced that its chief executive officer Brian Lian PhD will deliver a corporate presentation as part of the HC. Viking Therapeutics stock price has been showing a declining tendency so we believe that similar market segments were not very. The weighted average target price per AN2 Therapeutics share in Aug 2022 is.

SAN DIEGO Jan. Monday 28th Feb 2022 VKTX stock ended at 335. 2022 Search Stock FX pair Crypto or Commodity.

VIKING THERAPEUTICS INC stock price forecast for further price development up to 075 time horizon. Announced that they will report Q4 2021 results After-Market on Feb 09 2022. In Aug the negative dynamics for Momo shares will prevail with possible monthly volatility of 7317 volatility is expected.

Aprea Therapeutics APRE -495 Viking Therapeutics VKTX -393 and Vaxart VXRT -689 each sport clinical-stage assets capable of being major growth drivers in the years to come. Viking Therapeutics Inc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences. 52 rows Avidity Biosciences and Viking Therapeutics NASDAQVKTX are both small-cap medical companies but which is the better stockWe will compare the two companies based on the strength of their community ranking profitability analyst recommendations dividends media sentiment institutional ownership earnings risk and valuation.

Viking Therapeutics Stock Price Quote NASDAQ. NASDAQ Updated Mar 23 2022 947 PM. Viking Therapeutics Stock Forecast VKTX stock price prediction.

VKTX VIKING THERAPEUTICS INC. The best long-term short-term Viking Therapeutics share price prognosis for 2022 2023 2024 2025. This is 233 less than the trading day before Friday 25th Feb 2022.

Viking Therapeutics Inc Stock Forecast and Price Prognosis Data for 2022. During the day the stock fluctuated 360 from a day low at 333 to a day high of 345. Interactive Viking Therapeutics Inc.

The average Viking Therapeutics stock forecast 2022 represents a 1904 increase from the last price of 336999988555908. May 21 Jul 21 Sep 21 Nov 21 Jan 22 Mar 22 0 2500 5000 7500 10000 12500. VKTX 319 014 420 Post-Market 011 345 17603.

To Report Q4 2021 Results on Feb 09 2022. 7 brokers have issued 12-month price targets for Viking Therapeutics stock. Viking Therapeutics s earnings in 2022 is -54990000On average 7 Wall Street analysts forecast VKTXs earnings for 2022 to be -67392097 with the lowest VKTX earnings forecast at -77579275 and the highest VKTX earnings forecast at -58772178.

Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder owning 582M shares representing 743 of. Stock Price and Discussion Stocktwits. For Viking Therapeutics stock forecast for 2023 12 predictions are offered for each month of 2023 with average Viking Therapeutics stock forecast of 659 a high forecast of 726 and a low forecast of 525.

About the Viking Therapeutics Inc stock forecast. Find the latest Viking Therapeutics Inc.

Vktx Stock Price And Chart Nasdaq Vktx Tradingview